{"id":"W4324136985","doi":"10.1200/jco.2023.41.6_suppl.177","title":"Oral EPI-7386 in patients with metastatic castration-resistant prostate cancer.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Androgen receptor; Enzalutamide; Adverse effect; Pharmacokinetics; Internal medicine; Oncology; Pharmacodynamics; Antiandrogen; Pharmacology; Abiraterone acetate; Abiraterone; Tolerability; Cancer; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002464623,0.0004205754,0.0006865502,0.0001951271,0.0002068839,0.0003105901,0.0001866974,0.000239956,0.002039277],"category_scores_gemma":[0.0001991719,0.000159652,0.0002869118,0.000347398,0.0002199708,0.0001993212,0.0001310402,0.000681399,0.0004750408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003804033,"about_ca_system_score_gemma":0.0007096801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00143084,"about_ca_topic_score_gemma":0.004967911,"domain_scores_codex":[0.9999187,0.00002278403,0.000005487465,0.0000136032,0.0000173012,0.0000221855],"domain_scores_gemma":[0.99989,0.00001988335,0.00002447148,0.000005699436,0.000007304136,0.00005271516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2010741,0.01412038,0.08246058,0.002016368,0.0009413587,0.002064636,0.0003477263,0.005214831,0.072666,0.0004971791,0.01086829,0.6077287],"study_design_scores_gemma":[0.102481,0.4516689,0.3887751,0.0001765932,0.001127235,0.00624022,0.0001714576,0.004754207,0.01204554,0.0005727909,0.03191838,0.0000686358],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884529,0.006199836,0.0002396667,0.000224062,0.00004146762,0.0004361917,0.0006554742,0.00006850855,0.003681902],"genre_scores_gemma":[0.9954756,0.001994879,0.0003044519,0.0002499364,0.00005971711,0.0001045359,0.0006724029,0.000006320808,0.001132143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002039277,"threshold_uncertainty_score":0.006822109,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1872818187061182,"score_gpt":0.5233139718776647,"score_spread":0.3360321531715465,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}